Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

NCT01848561 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT01848561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01848561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Non-Interventional Postmarketing Study to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
April 29, 2013
Completion date
June 30, 2028
Enrollment
8,250 (estimated)
Sites
512

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis (uc)